CIK 0001088856
CORT CORCEPT THERAPEUTICS INC
Insider trading from SEC Form 4. Last filing Dec 31, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at CORCEPT THERAPEUTICS INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 11Weak | sell10b5-1 | Swisher Daniel N JR director | $131k | 2,200 | -100% | - | |
| 44Moderate | sell 3 | Lyon Joseph Douglas See Remarks | $80k | 1,411 | -14% | - | |
| 46Moderate | sell 3 | Robb Gary Charles Chief Business Officer | $147k | 2,609 | -11% | - | |
| 26Weak | sell 410b5-1 | Swisher Daniel N JR director | $132k | 2,200 | -100% | - | |
| 26Weak | sell 210b5-1 | Guyer William Chief Development Officer | $490k | 10,000 | -81% | - |
Transactions
The last 29 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 27, 2024 | WILSON JAMES N director | GGift Common Stockindirect: James N. Wilson and Pamela D. Wilson Trust | -7,800 | $0.00 | $0 | 1,306,226 | Dec 31, 2024 |
| Dec 10, 2024 | Swisher Daniel N JR director | MOption exercise Common Stock10b5-1 | +2,200 | $12.13 | $27k | 2,200 | Dec 12, 2024 |
| Dec 10, 2024 | Swisher Daniel N JR director | SOpen-market sale Common Stock10b5-1 | -2,200 | $59.46 | $131k | 0 | Dec 12, 2024 |
| Dec 10, 2024 | Swisher Daniel N JR director | MOption exercise Stock option (right to buy)derivative10b5-1 | -2,200 | $0.00 | $0 | 10,600 | Dec 12, 2024 |
| Dec 2, 2024 | Mokari Atabak Chief Financial Officer | FTax withholding Common Stock | -182 | $57.68 | $10k | 12,336 | Dec 4, 2024 |
| Dec 2, 2024 | Guyer William Chief Development Officer | FTax withholding Common Stock | -309 | $57.68 | $18k | 5,487 | Dec 4, 2024 |
| Dec 2, 2024 | Lyon Joseph Douglas See Remarks | FTax withholding Common Stock | -165 | $57.68 | $9,517 | 8,329 | Dec 4, 2024 |
| Dec 2, 2024 | Maduck Sean See Remarks | FTax withholding Common Stock | -295 | $57.68 | $17k | 84,788 | Dec 4, 2024 |
| Dec 2, 2024 | Robb Gary Charles Chief Business Officer | FTax withholding Common Stock | -324 | $57.68 | $19k | 19,539 | Dec 4, 2024 |
| Dec 2, 2024 | Maduck Sean See Remarks | AGrant or award Common Stock | +265 | $59.21 | $16k | 85,053 | Dec 4, 2024 |
| Dec 2, 2024 | Robb Gary Charles Chief Business Officer | AGrant or award Common Stock | +290 | $59.21 | $17k | 19,829 | Dec 4, 2024 |
| Dec 2, 2024 | Lyon Joseph Douglas See Remarks | AGrant or award Common Stock | +215 | $59.21 | $13k | 8,544 | Dec 4, 2024 |
| Dec 2, 2024 | Mokari Atabak Chief Financial Officer | AGrant or award Common Stock | +231 | $59.21 | $14k | 12,567 | Dec 4, 2024 |
| Dec 2, 2024 | Robb Gary Charles Chief Business Officer | AGrant or award Common Stock | +290 | $0.00 | $0 | 20,119 | Dec 4, 2024 |
| Dec 2, 2024 | Mokari Atabak Chief Financial Officer | AGrant or award Common Stock | +231 | $0.00 | $0 | 12,798 | Dec 4, 2024 |
| Dec 2, 2024 | Maduck Sean See Remarks | AGrant or award Common Stock | +265 | $0.00 | $0 | 85,318 | Dec 4, 2024 |
| Dec 2, 2024 | Lyon Joseph Douglas See Remarks | AGrant or award Common Stock | +215 | $0.00 | $0 | 8,759 | Dec 4, 2024 |
| Nov 22, 2024 | Lyon Joseph Douglas See Remarks | SOpen-market sale Common Stock | -1,411 | $56.72 | $80k | 8,494 | Nov 26, 2024 |
| Nov 22, 2024 | Robb Gary Charles Chief Business Officer | SOpen-market sale Common Stock | -2,609 | $56.20 | $147k | 20,163 | Nov 26, 2024 |
| Nov 22, 2024 | Robb Gary Charles Chief Business Officer | GGift Common Stock | -300 | $0.00 | $0 | 19,863 | Nov 26, 2024 |
| Nov 11, 2024 | Swisher Daniel N JR director | MOption exercise Common Stock10b5-1 | +2,200 | $12.13 | $27k | 2,200 | Nov 13, 2024 |
| Nov 11, 2024 | Swisher Daniel N JR director | SOpen-market sale Common Stock10b5-1 | -2,200 | $59.88 | $132k | 0 | Nov 13, 2024 |
| Nov 11, 2024 | Swisher Daniel N JR director | MOption exercise Stock option (right to buy)derivative10b5-1 | -2,200 | $0.00 | $0 | 12,800 | Nov 13, 2024 |
| Nov 1, 2024 | Guyer William Chief Development Officer | MOption exercise Common Stock10b5-1 | +6,606 | $21.65 | $143k | 12,402 | Nov 5, 2024 |
| Nov 1, 2024 | Guyer William Chief Development Officer | SOpen-market sale Common Stock10b5-1 | -6,606 | $48.97 | $323k | 5,796 | Nov 5, 2024 |
| Nov 4, 2024 | Guyer William Chief Development Officer | MOption exercise Common Stock10b5-1 | +3,394 | $21.65 | $73k | 9,190 | Nov 5, 2024 |
| Nov 4, 2024 | Guyer William Chief Development Officer | SOpen-market sale Common Stock10b5-1 | -3,394 | $48.97 | $166k | 5,796 | Nov 5, 2024 |
| Nov 1, 2024 | Guyer William Chief Development Officer | MOption exercise Stock option (right to buy)derivative10b5-1 | -6,606 | $0.00 | $0 | 453,394 | Nov 5, 2024 |
| Nov 4, 2024 | Guyer William Chief Development Officer | MOption exercise Stock option (right to buy)derivative10b5-1 | -3,394 | $0.00 | $0 | 450,000 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Guyer WilliamChief Development Officer
- Lyon Joseph DouglasSee Remarks
- Maduck SeanSee Remarks
- Mokari AtabakChief Financial Officer
- Robb Gary CharlesChief Business Officer
- Swisher Daniel N JRdirector
- WILSON JAMES Ndirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.